Drawing for IRIS

USPTO serial 97855498

IRIS

Reviewed by CopyMark Law Group

Reg. 7726808Status 700Registered
Filing date
Status date
Registration date
Mar 18, 2025
Examiner
LAIHO, DEVIN M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IRIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Syed Abedi

Syed Abedi SEED IP LAW GROUP LLP701 5TH AVENUE, SUITE 5400SEATTLE, WA 98104United States

Goods and services

ClassDescriptionStatusFirst use
001Clinical preparations in the nature of RNA and genetic material, namely, plasmids, DNA, and chemically-modified RNA encoding RNA for use in the manufacture of medical preparations for treatment of genetic diseasesACTIVEAug 9, 2023
005Pharmaceutical preparations for the treatment of genetic diseases, namely, neurological diseases; pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of genetic diseases, namely, neurological diseasesACTIVEAug 9, 2023
042Development of pharmaceutical preparations and medicines for genetic diseases, namely, neurological diseases; testing, inspection, research, and development of pharmaceutical preparations for genetic diseases, namely, neurological diseases; none of the foregoing research services directed to providing a database comprising patient records to others in the fields of eyecare or ophthalmologyACTIVEJun 13, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 18, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 18, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 28, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 28, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 22, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 25, 2024EXPTEXPARTE APPEAL TERMINATED—
Oct 25, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 25, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 29, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 29, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 29, 2024EXPIEX PARTE APPEAL-INSTITUTED—
Jul 29, 2024JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jul 29, 2024EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Jul 12, 2024AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jul 12, 2024PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 23, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 23, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jan 29, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 29, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 29, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 23, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 22, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 22, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 3, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 29, 2023AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED—
Sep 28, 2023IUAAUSE AMENDMENT ACCEPTED—
Sep 23, 2023AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Sep 23, 2023IUAFUSE AMENDMENT FILED—
Sep 22, 2023EAAUTEAS AMENDMENT OF USE RECEIVED—
Sep 14, 2023DOCKASSIGNED TO EXAMINER—
Apr 18, 2023MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 16, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 28, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance